Back to Journals » Vascular Health and Risk Management » Volume 16

Review

Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects

       
Total article views   HTML views PDF downloads Totals
6,213 Dovepress* 5,265+ 1,308 6,573
PubMed Central* 948 330 1,278
Totals 6,213 1,638 7,851
*Since 7 October 2020

View citations on PubMed and Google Scholar